Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rodrigo Riera-Sala"'
Autor:
Jordi Guzmán‐Casta, Sonia Carrasco‐CaraChards, Jorge Guzmán‐Huesca, Carla Paola Sánchez‐Ríos, Rodrigo Riera‐Sala, José Fabián Martínez‐Herrera, Erika Sagrario Peña‐Mirabal, Diana Bonilla‐Molina, Jorge Arturo Alatorre‐Alexander, Luis Manuel Martínez‐Barrera, Jerónimo Rafael Rodríguez‐Cid
Publikováno v:
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Abstract Background Malignant pleural mesothelioma is an infrequent neoplasia with a poor prognosis and the majority of patients already have advanced disease at the time of presentation. Exposure to asbestos is the most important risk factor for mal
Externí odkaz:
https://doaj.org/article/7bd83ef32c1c460d930b9e6993ead98d
Autor:
Jeronimo Rafael Rodriguez-Cid, Juan Jose Juarez-Vignon Whaley, Gisela Sánchez-Domínguez, Jordi Guzmán-Casta, Sonia Carrasco-CaraChards, Jorge Guzmán-Huesca, Rodrigo Riera-Sala, Carla Paola Sánchez-Ríos, Mayte Cruz-Zermeño, Alec Seidman-Sorsby, Ivan de Jesús Rodríguez-Zea, Jorge Arturo Alatorre-Alexander, Luis Manuel Martínez-Barrera, Patricio Javier Santillán-Doherty, Aminadab Godina-Flores, Victoria Imaz-Olguin, Ricardo Sosa-Sánchez, Dan Green-Renner
Publikováno v:
Journal of cancer research and clinical oncology.
Thoracic sarcomas are rare malignancies, with limited data for unresectable/advanced scenarios. Our goal is to provide insights of a three-drug chemotherapy regimen improving patient survival compared to standard regimens.Retrospective cohort analysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fb17ea86ec6a9d596c65bcf0bb5ed8b
https://pubmed.ncbi.nlm.nih.gov/36463530
https://pubmed.ncbi.nlm.nih.gov/36463530
Autor:
Julio César Garibay-Díaz, José Fabián Martínez-Herrera, Carla Paola Sánchez-Ríos, Julián Diaz-Rico, Jerónimo Rafael Rodríguez-Cid, Adriana Martinez-Camacho, Luis Manuel Martínez-Barrera, Jorge Arturo Alatorre-Alexander, Rodrigo Riera-Sala, Rodrigo Rafael Flores-Mariñelarena, Patricio Santillán-Doherty, Iván Romarico González-Espinoza, Anna Gozalishvili-Boncheva, Sonia Carrasco-Cara Chards, Vanessa García-Montes, Jordi Guzmán-Casta, Osvaldo Hernández-Flores
Publikováno v:
Lung Cancer Management
Background: Immunotherapy has demonstrated an improved overall survival (OS) and progression-free survival (PFS) as second-line treatment and subsequent lines compared with chemotherapy. Materials and methods: This was a retrospective review among ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011cb461c911084a20284a7f5cb9141d
http://europepmc.org/articles/PMC8369526
http://europepmc.org/articles/PMC8369526
Autor:
Jordi Guzmán-Casta, Rodrigo Riera-Sala, Luis Manuel Martínez-Barrera, Jerónimo Rafael Rodríguez-Cid, Carla Paola Sánchez-Ríos, Diana Bonilla-Molina, Sonia Carrasco-CaraChards, Erika Sagrario Peña-Mirabal, Jorge Arturo Alatorre-Alexander, Jorge Guzmán-Huesca, José Fabián Martínez-Herrera
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Background Malignant pleural mesothelioma is an infrequent neoplasia with a poor prognosis and the majority of patients already have advanced disease at the time of presentation. Exposure to asbestos is the most important risk factor for malignant pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc5d794c2993146886056283f0d4905
https://pubmed.ncbi.nlm.nih.gov/33660947
https://pubmed.ncbi.nlm.nih.gov/33660947
Autor:
Rodriguez-Cid, Jeronimo Rafael, Juarez-Vignon Whaley, Juan Jose, Sánchez-Domínguez, Gisela, Guzmán-Casta, Jordi, Carrasco-CaraChards, Sonia, Guzmán-Huesca, Jorge, Riera-Sala, Rodrigo, Sánchez-Ríos, Carla Paola, Cruz-Zermeño, Mayte, Seidman-Sorsby, Alec, de Jesús Rodríguez-Zea, Ivan, Alatorre-Alexander, Jorge Arturo, Martínez-Barrera, Luis Manuel, Santillán-Doherty, Patricio Javier, Godina-Flores, Aminadab, Imaz-Olguin, Victoria, Sosa-Sánchez, Ricardo, Green-Renner, Dan
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Aug2023, Vol. 149 Issue 9, p5479-5491, 13p